英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Lyell查看　Lyell　在百度字典中的解释百度英翻中〔查看〕
Lyell查看　Lyell　在Google字典中的解释Google英翻中〔查看〕
Lyell查看　Lyell　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Pioneering Transformative T-Cell Therapies | Lyell
    At Lyell, we are driven by our mission and focused on developing transformative therapies to improve the lives of patients Join our team of ambitious Lyellites who are committed to defeating cancer through innovation
  • Our Pipeline - Lyell
    Lyell, Epi-R, Stim-R, LyFE Manufacturing Center and the Lyell logo are trademarks owned by Lyell Immunopharma, Inc About Us Our Story Our Team Our Science Our Technology Bibliography Lyell Publications Presentations Our Pipeline Our Cell Therapies Cell Therapy Our Product Candidates Expanded Access Policy
  • Our Team - Lyell
    Lyell is a clinical-stage cell therapy company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors We are pioneering novel technology designed to generate T cells that drive long-lasting clinical response
  • Investor Relations - Lyell Immunopharma, Inc.
    The Investor Relations website contains information about Lyell Immunopharma, Inc 's business for stockholders, potential investors, and financial analysts
  • Lyell Immunopharma Announces Oral Presentation of New Clinical Data . . .
    SOUTH SAN FRANCISCO, Calif , May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, today announced that an abstract highlighting new clinical data from the Phase 1 2 trial of LYL314 (formerly IMPT-314) in large B
  • Our Cell Therapies | Lyell
    Learn more about Lyell's approach and capabilities to tackling solid tumors with cell therapy At Lyell, we are applying our technology to reprogram chimeric antigen receptor (CAR) T cells to resist exhaustion and remain potent
  • Lyell Immunopharma Strengthens Clinical and Commercial Capabilities . . .
    “As Lyell prepares to move forward with two pivotal programs designed to advance LYL314 towards approval for patients with aggressive large B-cell lymphoma, we are delighted to welcome leaders who further strengthen and bring new expertise to our Board of Directors and our Executive Committee,” said Lynn Seely, MD, Lyell’s President and
  • Our Story - Lyell
    Lyell is a clinical-stage cell therapy company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors We are pioneering novel technology designed to generate T cells that drive long-lasting clinical response
  • Contact Us - Lyell
    For general inquiries or to request additional information, please contact us at contact lyell com





中文字典-英文字典  2005-2009